IL-6 is a key mediator of cancer-related inflammation[21];high plasma levels of IL-6 were shown to predict a poor prognosis in patients with gastric cancer.[4] Collecting these evidences, the important role in inflammatory response might be the potential mechanism for the observed association of cytokines with gastric cancer progression in the present study. Here, IL6 is linked to cancer.